The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: lamivudine     Quarter: 2016Q3

Total Records: 443     Number of Pages: 23

DRUGNAME PT EventCount
LAMIVUDINE. Abortion spontaneous 6
LAMIVUDINE. Adverse event 6
LAMIVUDINE. Blood phosphorus decreased 6
LAMIVUDINE. Fanconi syndrome 6
LAMIVUDINE. Gastric ulcer 6
LAMIVUDINE. Hepatic cirrhosis 6
LAMIVUDINE. Hepatic failure 6
LAMIVUDINE. Premature baby 6
LAMIVUDINE. Premature delivery 6
LAMIVUDINE. Proteinuria 6
LAMIVUDINE. Renal impairment 6
LAMIVUDINE AND ZIDOVUDINE Maternal exposure during pregnancy 5
Lamivudine and Zidovudine Tablets Foetal exposure during pregnancy 5
LAMIVUDINE. Acute kidney injury 5
LAMIVUDINE. Diabetes mellitus 5
LAMIVUDINE. Disease recurrence 5
LAMIVUDINE. Drug tolerance 5
LAMIVUDINE. Hepatic enzyme abnormal 5
LAMIVUDINE. Hepatitis B surface antigen positive 5
LAMIVUDINE. Nausea 5

Total Records: 443     Number of Pages: 23